Background: Medicare Part D increased economic access to medications, but its effect on population-level health outcomes and use of other medical services remains unclear.
T
he broader implications of the Medicare prescription drug insurance benefit (Part D) are of national importance because the benefit substantially increased access to prescription drugs for more than 47 million older adults and adults with disabilities (1) . Since its implementation in 2006, Part D has become so widespread that even patient groups who previously had drug coverage substantially increased their medication use (1) ; nonadherence related to difficulties in paying for medication also declined (2, 3) . Medication use can influence health; however, little is known about the role of Part D in improving the health of the Medicare population, reducing the need for other medical services, or changing the efficiency of care.
Several studies have detected encouraging reductions in spending on nondrug medical services after Part D implementation, but all used data from the early transition years (2006 to 2007) and were limited by a focus on population subgroups, particularly those who voluntarily enrolled to obtain drug coverage or more generous coverage (4) . These self-selected enrollees were likely to differ from other subgroups in unmeasured ways and to be better prepared to take advantage of their new coverage. Their experience with Part D is probably more striking than that of the entire Medicare population on average. Medicare beneficiaries with limited or no drug benefits before 2006 saw statistically significant decreases in nondrug medical spending after enrolling in Part D (5, 6) . Medicare hospitalizations decreased after Part D implementation in states where preimplementation drug coverage rates had been especially low (7) . These associations in selected subgroups may not be generalizable to the larger Medicare population, however, because most of the population previously had drug coverage (8). Nevertheless, the U.S. Congressional Budget Office, partially in response to the subgroup evaluations, recently adopted a new costing method that assumes that increases in prescription fills at the full population level offset overall costs in other Medicare services (9) .
To address the lack of information about possible population-wide cost offsets associated with Part D, we estimated changes in health outcomes and medical services across the entire community-dwelling Medicare population to determine its comprehensive longterm policy effects. We used 11 years of survey data from the Medicare Current Beneficiary Survey (MCBS) (2000 to 2010 [latest data available]). To our knowledge, this is the only data set with nationally representative information on the health, functioning, and health service use of both the fee-for-service and Medicare Advantage populations. Medicare Advantage enrollees are a large and growing segment of the Medicare population, and they are missing in Medicare claims-based evaluations. We used a longitudinal study design with strong external validity for assessing the national implications of Part D (8). We hypothesized that, in the absence of Part D, population-level trends in health and medical services would have followed previously established trends; any statistically significant and consistent change in those trends after 2006 may be attributable to Part D.
METHODS
The MCBS is a continuous face-to-face panel survey of a representative national sample of Medicare enrollees conducted by the Centers for Medicare & Medicaid Services (10) . Since 1991, the MCBS has provided detailed longitudinal data on annual samples of Medicare enrollees, with a current sample size of approximately 12 000 community-dwelling and institutionalized elderly and disabled beneficiaries. The rich variety of measures includes demographic information, income, assets, living arrangements, family support, health status, changes in health status, functioning, health behaviors, health insurance coverage, drug coverage, health services use (including services not covered), and access to medical services.
The sample for the MCBS is extracted from Medicare enrollment records according to a multistage rotating panel sampling plan, with the sample replenished each year to remain representative. Respondents are interviewed in person 3 times a year using computer-assisted personal interviewing, which yields very high response rates (initially about 85%). The typical MCBS interview lasts approximately 1 hour. Cycles begin with a comprehensive annual fall interview on health status. Subsequent interviews collect additional details on health care use and expenditures that are aggregated into annual measures. Each respondent is asked to keep a record of insurance statements and receipts to enhance the accuracy of data. Self-reported use is validated using standard methods, such as construct validation, and the MCBS uses outcome measures that had previously been extensively validated, such as perceived health status and functioning. Medicare claims data are available for the subset of respondents enrolled in the fee-for-service Medicare program. Our analysis used the MCBS Cost and Use files, the survey's main source of data on health services use, through 2010 (the most recent year available) but also included fee-for-service claims as confirmatory analyses in the subgroup in which they were available.
Sample
The sample included community-dwelling Medicare enrollees from 2000 through 2010. We excluded institutionalized respondents for whom MCBS does not collect information about medical care use. Our annual samples ranged from 11 761 in 2000 to 9760 in 2010. When we accounted for overlapping panels across years of data, the total sample was 56 293 unique persons who contributed 120 566 person-years to this study.
An important feature of our sample is the inclusion of Medicare enrollees who are in the managed care program (Medicare Advantage). Participation in Medicare Advantage is voluntary, and enrollment nearly doubled during this period, from a low of 13% of the Medicare population in 2003 to a high of 24% in 2010 (11). However, Medicare Advantage enrollees do not have Medicare claims. Part D evaluations based on only Medicare claims may be susceptible to confounding biases due to this increase in Medicare Advantage enrollment. We included these enrollees in our evaluation and excluded them only when comparing self-reported use with claims-based use, which required identifying the subgroup with full-year Medicare Parts A and B feefor-service coverage.
In addition, we identified a vulnerable subgroup with cardiovascular disease as persons who reported that a physician had previously told them that they had atherosclerosis, angina pectoris, coronary heart disease, high blood pressure, heart attack, or stroke (or equivalent terms); this population is especially dependent on access to effective medications. The proportion of enrollees with cardiovascular disease increased gradually over time, ranging from 66% to 73% of the total annual samples. (Results from the cardiovascular subgroup analysis are available in the Appendix Table  1 , available at annals.org.)
Study Variables

Health Status
We used previously validated measures to assess changes in the proportion of enrollees reporting poor health outcomes (12, 13) , which was a strong predictor of adverse clinical outcomes. The negative outcomes included a self-rated general health status of either fair or poor, as opposed to excellent, very good, or good. We also defined any functional health status limitations as self-reported difficulty performing any of 6 activities of daily living (ADLs) (for example, bathing without help) and, separately, any of 8 instrumental ADLs (for
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Emergency Department and Inpatient Utilization
We used survey-reported health care encounters during the year as the primary way to assess use of medical services because these measures are also available for the Medicare Advantage population, whose use is not captured in Medicare claims data. Self-reported use is somewhat lower than claims-based use, but the underreporting is consistent over time (14) . To show this, we also compared changes after Part D in survey-based use and claims-based use for the subgroup of persons with both types of data available. Annual prevalence rates of self-reported medical service use were measured as the proportion of the sample reporting any emergency department visit or any hospitalization. We also calculated annual mean counts of emergency department visits, hospitalizations, hospital days per person, and mean total costs for emergency department and inpatient services. All costs were adjusted to 2010 U.S. dollars using the consumer price index to account for inflation (15). Quarterly mean counts and prevalence rates were measured for the fee-for-service sample with claims for emergency department visits or hospitalizations in each calendar quarter.
Other measures included age, sex, race and Hispanic ethnicity, geographic residence, disease burden as measured by a count of specific conditions, Medicaid enrollment, income, and prescription drug coverage (3, 12) . All variables were self-reported by survey respondents, except for sex, Medicaid enrollment, and age, which come from Medicare's administrative files. Drug coverage was measured by using a combination of Medicare administrative records (Part D or Medicaid) and self-reported drug coverage.
Statistical Analysis
All analyses used MCBS cross-sectional weights to represent the overall population of communitydwelling Medicare enrollees (10) . Further details about the probability-weighted file structure of the MCBS are available in the Appendix (available at www.annals .org). We examined demographic and health characteristics of the MCBS population across all study years, from 2000 to 2010, to ensure stability. We calculated unadjusted frequencies and means for all study variables with 95% CIs from 2000 to 2010 and assessed their year-to-year consistency.
To model changes in health and use outcomes, we employed an interrupted time-series study design, generalized linear models, and survey data estimators suitable for handling probability weights and clustering within primary sampling units (16) . We used logit link for binary measures, negative binomial link for counts, and log link with ␥ distributions for costs. For each outcome, the model contained an intercept, an indicator of the trend before Part D, a dummy variable to capture the level change in 2006, and an indicator of the trend after Part D (2007 to 2010). We estimated models with quarterly measures for changes at 3 and 5 years after Part D to assess the stability and onset of trend changes.
We also adjusted our models for the following demographic characteristics: age, age squared, sex, and race and Hispanic ethnicity. Our model is based on the null hypothesis that the data would follow the historical trend (from 2000 to 2005) in the absence of Part D implementation. Results from an alternative modeling approach using generalized estimation equations are provided in Appendix Table 2 (available at www.annals .org). These models and a third approach based on aggregate time-series models and bootstrapping (not shown) yielded results nearly identical to those of the main models presented in this report.
We conducted all analyses using Stata, version 11.2 (StataCorp), and SAS, version 9.3 (SAS Institute); the a priori level of statistical significance was a P value less than 0.05. This study was approved by the Human Subjects Committee of the Harvard Pilgrim Health Care Institute.
Role of the Funding Source
The National Institute on Aging and the Agency for Healthcare Research and Quality had no role in the design and conduct of the study; collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. Table 1 shows the demographic and health characteristics of the community-dwelling Medicare population in 2000 and 2010 and the fee-for-service-only population; annual rates were also examined for the interim years, and the results were consistent. In general, the characteristics of the total MCBS communitydwelling population were stable over time and indicated steady increases in the proportion of enrollees younger than 65 years, the wealthier strata, and persons with multiple comorbid conditions. The exception to stable trends was drug coverage. In 2000, about one quarter of enrollees reported having no drug coverage. In 2006, this rate decreased sharply to 10%; by 2010, only 5% of enrollees reported having no drug coverage. Compared with the total population, the subgroup with full-year Medicare fee-for-service coverage was disproportionately older and had greater proportions of white or non-Hispanic persons and persons with nonmetropolitan residence; most important, Medicare enrollees with fee-for-service coverage more often lacked drug coverage before Part D (22.6% vs. 27.3% in 2000).
RESULTS
Characteristics of Medicare Enrollees, From 2000 and 2010
Changes in Health Outcomes for Medicare Enrollees
As shown in Figure 1 and Table 2 , we found no evidence of improvements in the health outcomes of all Figure 2 and Table 2 show no consistent evidence of change in the use of emergency department or inpatient services 5 years after implementation of Part D relative to historical trends. Our statistical models indicate no significant changes in outcomes in the first 5 years after imple- Table 2) . Although a single data point occasionally reached statistical significance, these instances seem to be due to random variation rather than a true change in level or trend. We did not observe any decreases in hospital admissions or emergency department visits, the proportions of the population with fair or poor health, 1 or more ADL limitations, 1 or more instrumental ADL limitations, or enrollees who died during the year. Figure 3 and Table 3 show the results of our confirmatory analyses limited to the subgroup with full-year fee-for-service coverage. Using both annual surveybased and quarterly claims-based data, we detected no statistically significant change in use in 23 of 24 measures; the exception was a modest decrease in the trend of the number of emergency department visits (incidence rate ratio, 0.991 [CI, 0.983 to 0.998]), which was not apparent 3 years after Part D implementation and only weakly evident 5 years later.
Changes in Use and Spending
The analyses of changes in health status and use of medical services of the vulnerable subgroup reporting cardiovascular disease also showed no consistent evidence of changes from historical trends and were consistent with those in the total population (Appendix Table 1 ). 
DISCUSSION
Our study did not find a consistent link between the statistically significant and population-wide increases in prescription drug use attributed to Part D and population-level health improvements 5 years after the start of the program. We did not see any evidence of overall changes in self-reported health status or functional limitations, nor did we see reductions attributable to Part D in the use of inpatient and emergency department services.
Unlike earlier evaluations of Part D that used population subgroups (5-7), we did not find decreased hospital admissions, days, or spending in the national community-dwelling Medicare population. Previous studies used only 1 or 2 years of data before Part D implementation, which may have been insufficient to detect and control for the observed downward secular trends in hospital use. Given random year-to-year measurement variation, 1 or 2 years of measurement after Part D may also be insufficient to draw reliable conclusions. Further, previous studies examined Part D's effects in selected patient groups (for example, those without prior drug coverage who chose to enroll in Part D), which probably biases analyses because of associations among coverage choices and other characteristics and behaviors (17) . Our analysis was conducted in the entire community-dwelling Medicare population, including those in managed care, and was not subject to selection bias. Our previous evaluation found a 14% increase in prescription drug use in this same population within 2 years after implementation of Part D. Previous government analyses of Part D's effects in enrollees who only had fee-for-service Medicare also failed to detect any reductions in inpatient and emergency department events (18) .
The results of this study suggest that the Congressional Budget Office's decision to adopt a new method that presumes population-level offsetting savings from policies that increase prescription drug use, a decision based largely on previous Part D evaluations, may be premature. The Congressional Budget Office's estimates of Medicare spending on medical services are now routinely reduced by one fifth of 1% for each 1% increase in drug prescriptions filled. The budgetary effects of this assumption are not trivial. For example, provisions in the Patient Protection and Affordable Care Act to decrease Part D cost-sharing (by closing coverage gaps) are based on the Congressional Budget Office prediction that Medicare's nondrug spending will be reduced by $35 billion through cost savings in medical services, primarily through decreased hospitalizations (9) . Decreases in hospitalization during the first few years may indeed be possible, but they probably resulted from prior secular trends, rather than Part D, or were limited to selected subgroups.
Our study offers a unique combination of nationally representative data spanning 6 years before and 5 years after the implementation of Part D, a broad set of health status and service use measures, and a rigorous longitudinal study design. Our use of a time-series study design and generalized linear models allowed us to provide robust estimates of Part D's effects, especially after the early transitional years. To our knowledge, this study also offers one of the first assessments of whether the program had widespread effects across the entire community-dwelling Medicare population. Using self-reported medical services to ensure complete capture of the Medicare Advantage and fee-forservice Medicare populations is a unique feature of this study; this approach overcomes several common biases of claims-based studies, including omission of services provided at free clinics, services bundled into capitation arrangements that increased after Part D, and those not paid for by Medicare.
Our study has several limitations. The 6 years of prepolicy data provide an important comparison and context for our analyses. However, additional postpolicy years would provide more clarity about the longterm effects of implementing Part D. The first year of the new program was a transitional period. The selfreported measures may have been too crude to detect modest changes. Although measures of health status and physical function are most important for assessing In conclusion, in comparison to historical trends, we did not find evidence of improvements in population-level health outcomes or offsetting of emergency department and inpatient services in the 5 years after implementation of Medicare Part D. Further longterm longitudinal research is needed to determine whether certain demographic or clinical subgroups benefited more by implementation of Part D than others and whether policy changes beyond increasing access to medications are necessary for improving the health of the Medicare population and its efficient use of the health care system. . Estimated difference in trend between before and after Part D represents average change in trend exponentiated from log linear models adjusted for age, sex, and race. Survey models were based on 11 annual observation points, and claims models were based on 36 and 44 quarterly observation points. † Odds ratio. ‡ Incidence rate ratio.
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